General Information of Drug (ID: DMNDH3J)

Drug Name
Oraxol
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Phase 3 [1]
Gastric adenocarcinoma 2B72 Phase 3 [1]
Cross-matching ID
TTD ID
D04UWU
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)